A National Academies committee will consider the oversight and regulatory processes needed to ensure the public and such workers have access to effective respiratory protective devices and guidance on their use to mitigate exposures to inhalation hazards—including those arising during disasters and public health emergencies.
Other featured articles
Untangling the Price of Insulin
Despite its discovery nearly 100 years ago, insulin’s list price has been going up, not down. New Schaeffer Center research analyzes the flow of money across all distribution system participants—manufacturers, wholesalers, pharmacies, pharmacy benefit managers (PBMs), and health plans.
Financial Incentives and Other Nudges Do Not Increase COVID-19 Vaccinations among the Vaccine Hesitant
Can financial incentives, public health messages and other behavioral nudges –approaches deployed by state and local governments, employers, and health systems – increase SARS-CoV-2 vaccination rates among the vaccine hesitant in the US?